NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
RHHBY ROCHE HOLDING AG
- 42.040
- +0.250+0.60%
15min DelayClose Feb 26 16:00 ET
267.98BMarket Cap22.72P/E (TTM)
42.110High41.550Low11.46MVolume41.600Open41.790Pre Close480.57MTurnover0.18%Turnover Ratio21.03P/E (Static)6.37BShares42.43052wk High8.31P/B267.98BFloat Cap29.20052wk Low1.36Dividend TTM6.37BShs Float49.895Historical High3.22%Div YieldTTM1.34%Amplitude-3.794Historical Low41.936Avg Price1Lot Size
ROCHE HOLDING AG News
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)
Swiss Market Index Hits All-Time High -- Market Talk
Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News
Express News | FDA Says Semaglutide Injection Shortage Is Resolved As Of Feb 21
Pfizer Said to Be Discontinuing Roche-partnered Hemophilia Therapy Beqvez
Bernstein Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership With Roche
Roche Holding AG Falls Monday, Underperforms Market
Roche Elecsys SFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Reliable Way to Predict the Risk of Developing Severe Preeclampsia
Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk
Roche Holding Raised to Buy From Neutral by UBS
Roche Holding Target Raised to CHF338 From CHF300 by UBS
FDA Approves Genentech's Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
Zhongtai International: Maintains INNOVENT BIO 'Buy' rating, Target Price raised to HKD 43.85.
Zhuhai International released a research report stating that it maintains its "Buy" rating for INNOVENT BIO (01801), with the Target Price raised from HKD 42.45 to HKD 43.85 based on the adjusted DCF model. The company expects that the initial launch of Ma Shidu Peptide may increase sales promotions, and therefore, the sales expense forecast for 2025E has been raised by 9.3%. However, due to an increase in total revenue forecasts, the Shareholder Net income forecasts for 2025-26E have been raised by 0.1% and 4.6% respectively. Zhuhai International's main points are as follows: The company's product sales revenue is expected to grow rapidly in 2024 as planned, as recently announced for the full-year product sales in 2024.
Amazon has opened its first beauty and health products store in Milan, Italy.
Amazon, the giant e-commerce company from the USA, will open a store for beauty and health products in Milan, Italy, marking the company's latest experiment with physical stores. In a blog post, Amazon stated that this store is located in downtown Milan and primarily sells a range of beauty and Personal Care products, as well as over-the-counter medications. The first store, named Amazon Parafarmacia & Beauty, will be open to the public on Wednesday. The store will sell products from beauty and skincare brands including La Roche-Posay, Eucerin, and Vichy.
Roche Holding AG Falls Tuesday, Underperforms Market
TD Cowen Maintains ROCHE HOLDING AG(RHHBY.US) With Hold Rating, Maintains Target Price $43
Is Roche Holding AG (RHHBY) The Best Annual Dividend Stock To Buy Now?
Roche Holding AG Rises Monday
Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)